Ferghana Partners Group
  • About
    • Firm
    • Team
  • Expertise
    • Acquisitions
    • Divestments
    • Financings
    • Partnering
  • Sector Focus
    • Biotechnology
    • Diagnostics/Tools
    • Medical Devices
    • OTC Drugs
    • Pharmaceuticals
    • Specialty Chemicals
  • Transactions
  • Media
  • Contact
Blog
Home Press Release Mesoblast

Mesoblast

  • April 12, 2016
  • ferghanaadmin
  • Press Release

“Celgene Enters Into Equity Placement and Right of First Refusal Agreement”

Related Posts

BioPartnering Europe 2001

"Ninth Annual Conference (Part IV) Report"

Chemical Marker Reporter

"SCHERING AG; acquired rights for Refludan"

2nd Annual BIO European CEO & Investor Conference

Recent Posts
  • Clinical Orthopedic Society – Abstract #58
  • Clinical Orthopedic Society – Abstract #57
  • Celularity
  • Mina Therapeutics
  • Excision BioTherapeutics
Recent Comments
    Archives
    • May 2023
    • January 2018
    • November 2017
    • September 2017
    • August 2017
    • May 2017
    • May 2016
    • April 2016
    • October 2015
    Categories
    • Press Release
    • Publication
    Meta
    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    • Daktari Diagnostics
    • Anteo Diagnostics
    • Site Map
    • Contact
    • Home
    COPYRIGHT 2018 | ALL RIGHTS RESERVED | View our Privacy policy.